TOHO HOLDINGS CO., LTD. |
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 3,678 JPY | -0.16% |
|
-0.78% | +14.15% |
| Sales 2024 * | 1,414B 9.15B | Sales 2025 * | 1,404B 9.09B | Capitalization | 226B 1.46B |
|---|---|---|---|---|---|
| Net income 2024 * | 13.65B 88.36M | Net income 2025 * | 11.66B 75.49M | EV / Sales 2024 * | 0.16 x |
| Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | 0.16 x |
| P/E ratio 2024 * |
18
x | P/E ratio 2025 * |
20.7
x | Employees | 7,699 |
| Yield 2024 * |
0.98% | Yield 2025 * |
1.09% | Free-Float | 66.46% |
More Fundamentals
* Assessed data
More news
More press releases
| 1 day | -0.16% | ||
| 1 week | -0.78% | ||
| Current month | +0.71% | ||
| 1 month | +8.56% | ||
| 3 months | +13.55% | ||
| 6 months | +14.54% | ||
| Current year | +14.15% |
1 week
3 590.00
3 753.00
1 month
3 362.003 753.00
Current year
3 121.003 753.00
1 year
2 520.003 753.00
3 years
1 653.003 753.00
5 years
1 653.003 753.00
10 years
1 386.003 753.00
| Managers | Title | Age | Since |
|---|---|---|---|
Atsushi Udo
CEO | Chief Executive Officer | 60 | 87-06-30 |
Hiromi Edahiro
DFI | Director of Finance/CFO | 71 | 12-05-31 |
Makoto Kawamura
BRD | Director/Board Member | 63 | 15-06-30 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Norio Hamada
BRD | Director/Board Member | 84 | 66-09-30 |
Hiromi Edahiro
DFI | Director of Finance/CFO | 71 | 12-05-31 |
Shosaku Murayama
BRD | Director/Board Member | 74 | 14-05-31 |
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 0.38% | 32 M€ | +27.91% | ||
| 0.02% | 144,586 M€ | +15.01% |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-04-16 | 3,678 | -0.16% | 209 300 |
| 24-04-15 | 3,684 | +0.88% | 249,300 |
| 24-04-12 | 3,652 | +0.72% | 153,400 |
| 24-04-11 | 3,626 | -1.76% | 186,500 |
| 24-04-10 | 3,691 | -0.43% | 193,100 |
Delayed Quote Japan Exchange, April 16, 2024 at 02:00 am EDT
More quotes
Toho Holdings Co Ltd is a Japan-based company mainly engaged in the pharmaceutical wholesale business. The Company operates through five business segments. The Pharmaceutical Wholesale segment purchases pharmaceuticals and medical-related products from pharmaceutical manufacturers and sells them to hospitals, clinics and dispensing pharmacies. It is also engaged in the provision of data processing system and rental of real estate. The Dispensing Pharmacy segment is engaged in the management of insurance dispensing pharmacies and dispensing pharmacies. The Pharmaceutical Manufacture and Sale segment is engaged in the manufacture and sale of generic drugs and contract manufacturing of injectable drugs. The Clinical Trial Facility Support segment is engaged in the provision of support for clinical trial facilities. The Information Equipment Sales segment is engaged in the planning and sale of information processing equipment.
Sector
Pharmaceuticals
Calendar
2024-05-09
- Q4 2024 Earnings Release
Trading Rating
Investor Rating
ESG Refinitiv
C
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
4
Last Close Price
3,684
JPY
Average target price
3,152
JPY
Spread / Average Target
-14.43%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| +14.15% | 1.46B | |
| +12.89% | 68.68B | |
| +6.18% | 26.03B | |
| -4.35% | 7.86B | |
| +3.53% | 7.94B | |
| -28.85% | 7.13B | |
| +0.67% | 4.59B | |
| +19.12% | 4.39B | |
| 0.00% | 4.06B | |
| -3.51% | 3.85B |
- Stock Market
- Equities
- 8129 Stock
